Brian Luna, PhD

Assistant Professor

University of Southern California Keck School of Medicine

United States

Research Interests

Explore related searches

Professors in United States Professors in Microbiology Microbiology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Brian Luna, PhD, is an Assistant Professor at USC Keck School of Medicine in the United States. His research focuses on antimicrobial susceptibility testing, monoclonal antibody therapies, and the mechanisms of bacterial resistance, as demonstrated in his recent publications. Dr. Luna's work includes evaluating phagocytosis assays, defining minimum inhibitory concentrations for various pathogens, and exploring the efficacy of treatments against antibiotic-resistant strains.

Articles (12)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (4)

Emilia Caselli

Associate Professor

University of Modena and Reggio Emilia

ITALY

View details

Nicholas Skandalis

Associate Professor of Research Medicine

University of Southern California

UNITED STATES

View details

Hyungjin Eoh

Professor

University of Southern California

UNITED STATES

View details

Sarah Lindsey Miller

University of Southern California

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Brian Luna, PhD

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Evaluating antibody mediated opsonophagocytosis of bacteria via lab protocol: RAW 264.7 cell phagocytosis assay

Reply to “Limitations of repurposing ceftazidime for Stenotrophomonas maltophilia : a cautionary perspective”

Clinical assays rapidly predict bacterial susceptibility to monoclonal antibody therapy

Defining the minimum inhibitory concentration of 22 rifamycins in iron limited, physiologic medium against Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae clinical isolates

Therapeutic, Humanized Monoclonal Antibody Exhibits Broad Binding and Protective Efficacy against Acinetobacter baumannii

Antimicrobial Susceptibility Testing Performed in RPMI 1640 Reveals Azithromycin Efficacy against Carbapenem-Resistant Acinetobacter baumannii and Predicts In Vivo Outcomes in Galleria mellonella

In Vitro Activity of Rifabutin and Rifampin against Antibiotic-Resistant Acinetobacter baumannii, Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Klebsiella pneumoniae

Environmental Spread of Antibiotic Resistance

Synergistic Rifabutin and Colistin Reduce Emergence of Resistance When Treating Acinetobacter baumannii

A nutrient-limited screen unmasks rifabutin hyperactivity for extensively drug-resistant Acinetobacter baumannii

The Bactericidal Activity and Spore Inhibition Effect of Manuka Honey against Clostridioides Difficile

Horizontal Gene Transfer of Antibiotic Resistance from Acinetobacter baylyi to Escherichia coli on Lettuce and Subsequent Antibiotic Resistance Transmission to the Gut Microbiome

Collaborators (4)

Emilia Caselli

Nicholas Skandalis

Hyungjin Eoh

Sarah Lindsey Miller

Make your next move.